Sat.Jun 06, 2020 - Fri.Jun 12, 2020

article thumbnail

What Pharmaceutical Marketers Can Learn from the Coronavirus Response

Pharma Marketing Network

Many of us are now working from home. We’re accepting meeting invites that will be held via video conference and preparing to FaceTime our families after work. We are pivoting our lifestyles to fit the circumstances that COVID-19 has put us in. After lockdowns, isolations, and closures, we are starting to see the nation prepare to reopen. While New York City was one of the most severe areas for the pandemic, other regions of the state are ready to leave isolation.

article thumbnail

Will Your Insurance Cover Your Vitamins?

BuzzRx

Surveys have estimated that 77% of Americans take dietary supplements, and we spend approximately $35 billion yearly on these over-the-counter (OTC) products. The overwhelming majority (98%) of dietary supplements are minerals and vitamins. Some of these products are taken to treat specific symptoms, while others are taken as part of preventive health care practices because they are believed to prevent illness, boost immunity, aid weight loss , or supplement nutrition from dietary intake.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Can I Mix Nebulized Medications? Including Revefenacin

Med Ed 101

The administration procedure for inhalation therapy with nebulizers can be very lengthy and time-consuming. Because of this, many providers, pharmacists, nurses, and respiratory therapists could benefit from knowing which aerosolized medications may be combined to shorten this process. Patients also often ask, “Can I Mix Nebulized Medications”?

40
article thumbnail

A CONCISE REVIEW ON LIPOSOMES DRUG DELIVERY SYSTEM

Pharma Tutor

ABOUT AUTHORS. BHANDARI SALONI *, KISHNANI KHUSHBOO, RATHORE KAMAL SINGH . BN College of Pharmacy, Udaipur-Raj. 313001. salonibhandari1996.sb@gmail.com. ABSTRACT. Liposomes are concentric bilayer vesicles, which were first developed by Bangham and his colleagues in 1961. They are highly efficient having high drug entrapment capacity. Due to their size, hydrophobic and lipophilic character they are most widely used vehicles for drug delivery.

40
article thumbnail

Position Your Pharmacy for Expansion

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

article thumbnail

Ep. 002 – John Mack Podcast Transcript

Pharma Marketing Network

RJ Lewis (EHS): Hello, this is RJ Lewis and we’re back for Episode 2 with John Mack and Don Langsdorf, and we’re talking about the rebirth of Pharma Marketing and Pharma Guy. John Mack (PG): Thanks for the interview and I really appreciate talking about myself, but enough about me tell me about you and what you plan to do with pharma marketing?

article thumbnail

Ep. 003 – Ritesh Patel Podcast Transcript

Pharma Marketing Network

RJ Lewis (EHS): Hello, this is RJ Lewis from Pharma Marketing Network. I’ll be your host today. And I am very excited to have with us, Ritesh Patel. Ritesh sure most of you know him already. He’s known industry-wide. He’s the Chief Digital Officer for Health at Ogilvy. And he’s also a Pharma Marketing Network Editorial Advisory Board member.

More Trending

article thumbnail

Ep. 007 – Holly Henry and Kamran Shah Podcast Transcript

Pharma Marketing Network

RJ (PMN): Hi this is RJ Lewis, your host of the pharma marketing network podcast and I’m excited today to have with me a couple of executives from Klick Health to talk about CCPA. We have Holly Henry on the phone who is the chief medical officer of klick, and we also have Kamran Shah who is the EVP of technology and media. Welcome to the podcast!

HIPAA 40
article thumbnail

Ep. 006 – Mark Stinson & Bob Baurys Podcast Transcript

Pharma Marketing Network

Don (PMN): Hi good morning everyone, welcome to the pharma marketing podcast. I’m your host Don Langsdorf and I am here today with Bob Baurys and Mark Stinson from 83Bar and also the authors of patient activation. Bob and Mark thanks for joining us today. Bob (83Bar): Great to be here. Mark (83Bar): Yea thank you. Don (PMN): Wonderful. I think it would help our listeners to know a little bit about you first before we jump into the meat of the interview here.

article thumbnail

BCMTMS Exam Change, Free Book, and One Time Discount!

Med Ed 101

I am happy with the content we have put together for the BCMTMS exam and have received some nice comments from newly board-certified customers just like this one: “Hi Eric, I just wanted to let you know that I took your BCMTMS review course and I just found out I passed the exam. I worked […]. The post BCMTMS Exam Change, Free Book, and One Time Discount!

40
article thumbnail

Ep. 001 – John Mack Podcast Transcript

Pharma Marketing Network

RJ Lewis (EHS): Hello, this is RJ Lewis, the Founder, and CEO of eHealthcare Solutions. And I’m excited about today’s podcast. With me, today is John Mack, the original creator of Pharma Marketing and also known as Pharma Guy from far and wide. And I also have with me Don Langsdorf who’s our Director of Digital Solutions and Strategy.

article thumbnail

What the FDA's New Dosage Guidance Means for the Future of Clinical Research

Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist

What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.

article thumbnail

COVID – 19 DIAGNOSIS : A SHORT REVIEW

Pharma Tutor

ABOUT AUTHORS. Swarupananda Mukherjee*, Sohini Bera, Moumoyee Chakraborty . NSHM Knowledge Campus, Kolkata – Group of Institutions, Department of Pharmaceutical Technology, 124, B L Saha Road, Kolkata, India * Swarupananda.mukherjee@nshm.com. ABSTRACT : Corona viruses are a family of enveloped, positive stranded, single stranded RNA viruses. This corona virus family consists of pathogens of several human and animal species including SARS-CoV, NovelCOVID-19 but now referred to as SARS-CoV-2 by th

53
article thumbnail

Ep. 005 – Dave Chase Podcast Transcript

Pharma Marketing Network

Don (PMN): Hi welcome. This is Don Langsdorf with the Pharma Marketing Network pleased to welcome today Dave Chase, co-founder of the Health Rosetta. Good morning, Dave. Thanks for coming on the podcast and if you wouldn’t mind, could tell us a little bit about yourself. Dave (HR): Sure. Thanks for having me on. Quick background on myself. I started my career in consulting implementing systems inside of a couple dozen different hospitals and then I went on to find Microsoft’s healthc